A Systematic Review of Economic Evidence on Community Hypertension Interventions

Details

• Alternative Title:
  Am J Prev Med
• Personal Author:
  Zhang, Donglan ; Wang, Guijing ; Joo, Heesoo
• Description:
  Context ; Effective community-based interventions are available to control hypertension. It is important to determine the economics of these interventions. ; Evidence acquisition ; Peer-reviewed studies from January 1995 through December 2015 were screened. Interventions were categorized into educational interventions, self-monitoring interventions, and screening interventions. Incremental cost-effectiveness ratios were summarized by types of interventions. The review was conducted in 2016. ; Evidence synthesis ; Thirty-four articles were included in the review (16 from the U.S., 18 from other countries), including 25 on educational interventions, three on self-monitoring interventions, and six on screening interventions. In the U.S., five (31.3%) studies on educational interventions were cost saving. Among the studies that found the interventions cost effective, the median incremental costs were $62 (range, $40–$114) for 1-mmHg reduction in systolic blood pressure (SBP) and $13,986 (range, $6,683–$58,610) for 1 life-year gained. Outside the U.S., educational interventions cost from $0.62 (China) to $29 (Pakistan) for 1-mmHg reduction in SBP. Self-monitoring interventions, evaluated in the U.S. only, cost $727 for 1-mmHg reduction in SBP and $41,927 for 1 life-year gained. For 1 quality-adjusted life-year, screening interventions cost from $21,734 to $56,750 in the U.S., $613 to $5,637 in Australia, and $7,000 to $18,000 in China. Intervention costs to reduce 1 mmHg blood pressure or 1 quality-adjusted life-year were higher in the U.S. than in other countries. ; Conclusions ; Most studies found that the three types of interventions were either cost effective or cost saving. Quality of economic studies should be improved to confirm the findings.
• Subjects:
  • Article
  • Blood Pressure Monitoring, Ambulatory
  • Cost-Benefit Analysis
  • Humans
  • Hypertension
  • Patient Education as Topic
  • Program Evaluation
  • Quality-Adjusted Life Years
  • Treatment Outcome
• Source:
  Am J Prev Med. 53(6 Suppl 2):S121-S130
• Pubmed ID:
  29153113
• Pubmed Central ID:
  PMC5819001
• Document Type:
  Journal Article
• Funding:
  CC999999/Intramural CDC HHSUnited States/
• Volume:
  53
• Download URL:
  https://stacks.cdc.gov/view/cdc/52026/cdc_52026_DS1.pdf
• File Type:
  [PDF - 451.51 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:9faafcfdb7529954f6c6248bed5ebe84b6a76605ff5df1af4fad71793128420d